- LINKS
-
Our engagement for a better climate
Click here for more information about our commitment.
More information
-
- Bookmark this page
- gross
Investment in protecting the climate
By 2010, Bayer will have invested a billion euros in the research and development of climate-friendly processes and products.
In its group-wide Climate Program, the company has set itself ambitious targets for reducing greenhouse gases. These targets apply to all subgroups and divisions.
The Bayer HealthCare subgroup's goal is to reduce its specific greenhouse-gas emissions by a further five percent by 2020.
In its group-wide Climate Program, the company has set itself ambitious targets for reducing greenhouse gases. These targets apply to all subgroups and divisions.
The Bayer HealthCare subgroup's goal is to reduce its specific greenhouse-gas emissions by a further five percent by 2020.
Our engagement for a better climate
Click here for more information about our commitment.
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Testosterone deficiency
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
Country Links
Recommended Links
IFPMA Partnerships Book
EFPIA ─ Medicines for Mankind
